Testing of


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
21 10 2020
Historique:
received: 05 06 2020
accepted: 08 08 2020
pubmed: 21 8 2020
medline: 24 6 2021
entrez: 21 8 2020
Statut: epublish

Résumé

Azithromycin in combination with ceftriaxone is recommended as the first-line treatment for uncomplicated gonorrhea in many countries. Therefore, monitoring of azithromycin susceptibility of

Identifiants

pubmed: 32817227
pii: JCM.01398-20
doi: 10.1128/JCM.01398-20
pmc: PMC7587106
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Azithromycin 83905-01-5
Agar 9002-18-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

J Antimicrob Chemother. 2009 Aug;64(2):353-8
pubmed: 19468025
PLoS Med. 2017 Jul 7;14(7):e1002344
pubmed: 28686231
Int J STD AIDS. 2013 Feb;24(2):85-92
pubmed: 24400344
Sex Health. 2019 Sep;16(5):412-425
pubmed: 31437420
MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137
pubmed: 26042815
J Antimicrob Chemother. 2016 Nov;71(11):3096-3108
pubmed: 27432602
J Med Microbiol. 2018 Jan;67(1):68-73
pubmed: 29219803
N Engl J Med. 2016 Jun 23;374(25):2504-6
pubmed: 27332921
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Emerg Infect Dis. 1995 Apr-Jun;1(2):66
pubmed: 8903165
Clin Infect Dis. 2020 Feb 14;70(5):798-804
pubmed: 30963175

Auteurs

Ricardo Gianecini (R)

World Health Organization Collaborating Centre for Antimicrobial Resistance, National Reference Laboratory of Sexually Transmitted Diseases (STD), National Institute of Infectious Diseases-ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina.

Lucia Irazu (L)

National Institute of Infectious Diseases-ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina.

Marcelo Rodríguez (M)

National Institute of Infectious Diseases-ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina.

Paula Cristaldo (P)

World Health Organization Collaborating Centre for Antimicrobial Resistance, National Reference Laboratory of Sexually Transmitted Diseases (STD), National Institute of Infectious Diseases-ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina.

Claudia Oviedo (C)

World Health Organization Collaborating Centre for Antimicrobial Resistance, National Reference Laboratory of Sexually Transmitted Diseases (STD), National Institute of Infectious Diseases-ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina.

Marisa Turco (M)

Sección Microbiología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina.

Veronica Rodrigo (V)

Sección Microbiología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina.

Liliana Fernández Canigia (LF)

Laboratorio Bacteriología, Hospital Alemán, Buenos Aires, Argentina.

Ana Schneider (A)

Laboratorio Bacteriología, Hospital Alemán, Buenos Aires, Argentina.

Liliana Guelfand (L)

Laboratorio Bacteriología, Hospital Fernández, Buenos Aires, Argentina.

Laura Scocozza (L)

Laboratorio Bacteriología, Hospital Fernández, Buenos Aires, Argentina.

Patricia Galarza (P)

World Health Organization Collaborating Centre for Antimicrobial Resistance, National Reference Laboratory of Sexually Transmitted Diseases (STD), National Institute of Infectious Diseases-ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina pgalarza@anlis.gov.ar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH